Lipocine Inc. Email Format

Pharmaceutical ManufacturingUtah, United States11-50 Employees

Lipocine Inc. is a clinical-stage biopharmaceutical company focused on developing differentiated therapies through its proprietary lipid-based oral drug delivery platform (LIP’RAL®).

The company specializes in enabling effective oral delivery of challenging molecules, improving bioavailability, patient compliance, and therapeutic outcomes across key areas including metabolic, endocrine, and central nervous system disorders.

Lipocine’s portfolio includes TLANDO®, an FDA-approved oral testosterone therapy, along with a robust pipeline of clinical-stage programs targeting conditions such as postpartum depression, liver disease (NASH/cirrhosis), obesity, and preterm birth prevention.

Leveraging a 505(b)(2) regulatory strategy and global partnership model, Lipocine advances capital-efficient development programs designed to address large, underserved markets.

Founded in 1997 and headquartered in Salt Lake City, Utah, Lipocine is committed to delivering practical, patient-friendly therapeutic solutions through innovative oral drug delivery.

Sign up for free to view info

Company overview Employee directory